LCTX vs ACHV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACHV Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Achieve Life Sciences, Inc. (ACHV) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while LCTX counters with relative strength in Valuation. Fundamentally, LCTX trades at 30.7x Forward P/E with -280.3% operating margin (-61.0% YoY revenue) versus ACHV at 35.3x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, LCTX sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against ACHV sits in BREAKOUT (23rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LCTX | ACHV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $207.4M | $692.8M | Larger Scale | ACHV |
| Trailing P/E Ratio Valuation | 30.7x | 35.3x | Lower Multiple | LCTX |
| Forward P/E Ratio Valuation | 30.7x | 35.3x | Lower Multiple | LCTX |
| Revenue Growth (YoY) Growth | -61.0% | +0.0% | Higher Growth | ACHV |
| Operating Margin (TTM) Profitability | -280.3% | 0.0% | Higher Margin | ACHV |
| Net Profit Margin Profitability | 16.2% | 0.0% | Higher Margin | LCTX |
| Return on Equity (ROE) Capital Efficiency | 4.3% | -845.0% | Higher ROE | LCTX |
| 52-Week Range Position Momentum | 0% ($1โ$2) | 69% ($3โ$9) | Stronger Trend | ACHV |
| Beta / 30D Volatility Risk Regime | 1.39ฮฒ ยท 79% Vol | 1.73ฮฒ ยท 62% Vol | Lower Realized Risk | ACHV |
| Unified Institutional Score Composite Signal | 54.9 / 100 (HOLD) | 56.6 / 100 (HOLD) | Higher Composite | ACHV |